Literature DB >> 22001379

Rapidly progressive dementia: experience in a tertiary care medical center.

Isabel Sala1, Marta Marquié, María Belén Sánchez-Saudinós, Raquel Sánchez-Valle, Daniel Alcolea, Beatriz Gómez-Ansón, Teresa Gómez-Isla, Rafael Blesa, Alberto Lleó.   

Abstract

Diagnosis of rapidly progressive dementia (RPD) poses a complex medical challenge that requires an exhaustive evaluation. Although prion diseases, in particular Creutzfeldt-Jakob disease (CJD), are often suspected, many other nonprion diseases may present as RPD. Our aim was to review the causes of RPD in our center to better understand the underlying conditions. We reviewed clinical, neuroimaging, and cerebrospinal fluid data from patients with RPD admitted to our hospital from 1994 to 2009. Forty-nine patients (mean age at onset 72.4 y) with RPD were admitted to our center during the study period. The mean interval between the onset of symptoms and admission was 4.6 months. The final clinical diagnoses were as follows: nonprion neurodegenerative diseases (36.8%), CJD (30.6%), vascular dementia (8.2%), toxic-metabolic conditions (8.2%), and other disorders (16.2%). Among cases with informed death (n = 19), the average survival time was 8.6 ± 9.5 months. Survival was shorter among patients with prion disease (n = 10) than in those with other diagnoses (n = 9, P = 0.004). In conclusion, nonprion neurodegenerative diseases are the most common cause of RPD in our center. Our results suggest that although CJD is often suspected as a cause of RPD, its frequency depends on the referral differences across specialized centers.

Entities:  

Mesh:

Year:  2012        PMID: 22001379     DOI: 10.1097/WAD.0b013e3182368ed4

Source DB:  PubMed          Journal:  Alzheimer Dis Assoc Disord        ISSN: 0893-0341            Impact factor:   2.703


  16 in total

1.  Neurocognitive features distinguishing primary central nervous system lymphoma from other possible causes of rapidly progressive dementia.

Authors:  Mariel B Deutsch; Mario F Mendez
Journal:  Cogn Behav Neurol       Date:  2015-03       Impact factor: 1.600

2.  Creutzfeldt-Jakob disease presenting with encephalopathy, rigidity, and hyperekplexia.

Authors:  Justin Graveline; Gauruv Bose; Heather J MacLean
Journal:  Neurol Clin Pract       Date:  2019-10

3.  Ethics in prion disease.

Authors:  Kendra Bechtel; Michael D Geschwind
Journal:  Prog Neurobiol       Date:  2013-07-29       Impact factor: 11.685

4.  A Neurologist's Practical Approach to Cognitive Impairment.

Authors:  Philip W Tipton; Gregory S Day; Neill Graff-Radford
Journal:  Semin Neurol       Date:  2021-11-26       Impact factor: 3.420

5.  Glioblastoma with Gliomatosis Cerebri Growth Pattern Presenting as Rapidly Progressive Dementia.

Authors:  John Y Rhee; Luis Nicolas Gonzalez Castro
Journal:  Neurohospitalist       Date:  2022-02-11

Review 6.  Rapidly Progressive Dementia.

Authors:  Gregory S Day
Journal:  Continuum (Minneap Minn)       Date:  2022-06-01

Review 7.  Rapidly Progressive Dementia.

Authors:  Michael D Geschwind
Journal:  Continuum (Minneap Minn)       Date:  2016-04

8.  Rapidly Progressive Dementia in the Outpatient Clinic: More Than Prions.

Authors:  Gregory S Day; Erik S Musiek; John C Morris
Journal:  Alzheimer Dis Assoc Disord       Date:  2018 Oct-Dec       Impact factor: 2.703

9.  Determination of neuronal antibodies in suspected and definite Creutzfeldt-Jakob disease.

Authors:  Oriol Grau-Rivera; Raquel Sánchez-Valle; Albert Saiz; José Luis Molinuevo; Reyes Bernabé; Elvira Munteis; Francesc Pujadas; Antoni Salvador; Júlia Saura; Antonio Ugarte; Maarten Titulaer; Josep Dalmau; Francesc Graus
Journal:  JAMA Neurol       Date:  2014-01       Impact factor: 18.302

10.  Pathologically confirmed autoimmune encephalitis in suspected Creutzfeldt-Jakob disease.

Authors:  Peter Maat; Janet W de Beukelaar; Casper Jansen; Maaike Schuur; Cornelia M van Duijn; Marleen H van Coevorden; Esther de Graaff; Maarten Titulaer; Annemieke J Rozemuller; Peter Sillevis Smitt
Journal:  Neurol Neuroimmunol Neuroinflamm       Date:  2015-11-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.